MARY KAY BULTMAN: Open Payments
NPI 1639627110 · MILWAUKEE, WI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,421 in 46 payments from 7 companies in 2025. Trend: 2023 $696 · 2024 $1,149 · 2025 $1,421
Food & beverage: $1,309Education: $111
| Company | Payments | Amount |
|---|---|---|
| Alkermes, Inc. | 23 | $580 |
| Teva Pharmaceuticals USA, Inc. | 10 | $358 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 5 | $205 |
| Neurocrine BioSciences, Inc. | 2 | $140 |
| ABBVIE INC. | 4 | $89 |
| Indivior Inc. | 1 | $26 |
| LivaNova USA, Inc. | 1 | $22 |
Products named: ARISTADA, CAPLYTA, UZEDY, INGREZZA, LYBALVI, VRAYLAR, AUSTEDO XR, SUBLOCADE.
Industry payments across WI — which companies pay providers there.
